Radiation dose escalation using intensity modulated radiation therapy for gross unresected node-positive endometrial cancer

Practical Radiation Oncology

Volumn 4, Issue 2, 2014, Pages 90-98

  Townamchai, Kanokpis ^a   Poorvu, Philip D ^a   Damato, Antonio L ^a   DeMaria, Rebecca ^a   Lee, Larissa J ^a   Berlin, Suzanne ^a   Feltmate, Colleen ^a   Viswanathan, Akila N ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER CONTROL; CANCER LOCALIZATION; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CLINICAL ARTICLE; DISEASE FREE SURVIVAL; ENDOMETRIUM CANCER; FEMALE; HUMAN; HYSTERECTOMY; INOPERABLE CANCER; INTENSITY MODULATED RADIATION THERAPY; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PRIORITY JOURNAL; RADIATION DOSE DISTRIBUTION; RADIATION DOSE ESCALATION; RADIATION INJURY; SURVIVAL TIME; TREATMENT FAILURE; ENDOMETRIAL NEOPLASMS; KAPLAN MEIER METHOD; MIDDLE AGED; PATHOLOGY; POSITRON EMISSION TOMOGRAPHY; RADIATION DOSE; VERY ELDERLY;

AGED; AGED, 80 AND OVER; DISEASE-FREE SURVIVAL; ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; MIDDLE AGED; POSITRON-EMISSION TOMOGRAPHY; RADIOTHERAPY DOSAGE; RADIOTHERAPY, INTENSITY-MODULATED;

EID: 84896739831     PISSN: 18798500     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.prro.2013.07.002     Document Type: Article

References (20)

1. Varia M.A., Bundy B.N., Deppe G., et al. Cervical carcinoma metastatic to para-aortic nodes: extended field radiation therapy with concomitant 5-fluorouracil and cisplatin chemotherapy: a Gynecologic Oncology Group study. Int J Radiat Oncol Biol Phys 1998, 42:1015-1023.
2. Grigsby P.W., Singh A.K., Siegel B.A., Dehdashti F., Rader J., Zoberi I. Lymph node control in cervical cancer. Int J Radiat Oncol Biol Phys 2004, 59:706-712.
3. Grigsby P.W., Heydon K., Mutch D.G., Kim R.Y., Eifel P. Long-term follow-up of RTOG 92-10: cervical cancer with positive para-aortic lymph nodes. Int J Radiat Oncol Biol Phys 2001, 51:982-987.
4. Mundt A.J., Roeske J.C., Lujan A.E., et al. Initial clinical experience with intensity-modulated whole-pelvis radiation therapy in women with gynecologic malignancies. Gynecol Oncol 2001, 82:456-463.
5. Du X.L., Sheng X.G., Jiang T., et al. Intensity-modulated radiation therapy versus para-aortic field radiotherapy to treat para-aortic lymph node metastasis in cervical cancer: prospective study. Croat Med J 2010, 51:229-236.
6. Du X.L., Tao J., Sheng X.G., et al. Intensity-modulated radiation therapy for advanced cervical cancer: a comparison of dosimetric and clinical outcomes with conventional radiotherapy. Gynecol Oncol 2012, 125:151-157.
7. Roeske J.C., Lujan A., Rotmensch J., Waggoner S.E., Yamada D., Mundt A.J. Intensity-modulated whole pelvic radiation therapy in patients with gynecologic malignancies. Int J Radiat Oncol Biol Phys 2000, 48:1613-1621.
8. Chen M.F., Tseng C.J., Tseng C.C., Yu C.Y., Wu C.T., Chen W.C. Adjuvant concurrent chemoradiotherapy with intensity-modulated pelvic radiotherapy after surgery for high-risk, early stage cervical cancer patients. Cancer J 2008, 14:200-206.
9. Mundt A.J., Mell L.K., Roeske J.C. Preliminary analysis of chronic gastrointestinal toxicity in gynecology patients treated with intensity-modulated whole pelvic radiation therapy. Int J Radiat Oncol Biol Phys 2003, 56:1354-1360.
10. Esthappan J., Mutic S., Malyapa R.S., et al. Treatment planning guidelines regarding the use of CT/PET-guided IMRT for cervical carcinoma with positive paraaortic lymph nodes. Int J Radiat Oncol Biol Phys 2004, 58:1289-1297.
11. Mutic S., Malyapa R.S., Grigsby P.W., et al. PET-guided IMRT for cervical carcinoma with positive para-aortic lymph nodes-a dose-escalation treatment planning study. Int J Radiat Oncol Biol Phys 2003, 55:28-35.
12. Small W., Mell L.K., Anderson P., et al. Consensus guidelines for delineation of clinical target volume for intensity-modulated pelvic radiotherapy in postoperative treatment of endometrial and cervical cancer. Int J Radiat Oncol Biol Phys 2008, 71:428-434.
13. Poorvu P.D., Sadow C.A., Townamchai K., Damato A.L., Viswanathan A.N. Duodenal and other gastrointestinal toxicity in cervical and endometrial cancer treated with extended-field intensity modulated radiation therapy to paraaortic lymph nodes. Int J Radiat Oncol Biol Phys 2013, 85:1262-1268.
14. Shirvani S., Klopp A.H., Likhacheva A., et al. Intensity modulated radiation therapy for definitive treatment of paraortic relapse in patients with endometrial cancer. Pract Radiat Oncol 2013, 3:e21-e28.
15. Small W., Winter K., Levenback C., et al. Extended-field irradiation and intracavitary brachytherapy combined with cisplatin and amifostine for cervical cancer with positive para-aortic or high common iliac lymph nodes: results of arm II of Radiation Therapy Oncology Group (RTOG) 0116. Int J Gynecol Cancer 2011, 21:1266-1275.
16. Mundt A.J., Lujan A.E., Rotmensch J., et al. Intensity-modulated whole pelvic radiotherapy in women with gynecologic malignancies. Int J Radiat Oncol Biol Phys 2002, 52:1330-1337.
17. Kidd E.A., Siegel B.A., Dehdashti F., et al. Clinical outcomes of definitive intensity-modulated radiation therapy with fluorodeoxyglucose-positron emission tomography simulation in patients with locally advanced cervical cancer. Int J Radiat Oncol Biol Phys 2010, 77:1085-1091.
18. Salama J.K., Mundt A.J., Roeske J., Mehta N. Preliminary outcome and toxicity report of extended-field, intensity-modulated radiation therapy for gynecologic malignancies. Int J Radiat Oncol Biol Phys 2006, 65:1170-1176.
19. Roeske J.C., Bonta D., Mell L.K., Lujan A.E., Mundt A.J. A dosimetric analysis of acute gastrointestinal toxicity in women receiving intensity-modulated whole-pelvic radiation therapy. Radiother Oncol 2003, 69:201-207.
20. Portelance L., Chao K.S., Grigsby P.W., Bennet H., Low D. Intensity-modulated radiation therapy (IMRT) reduces small bowel, rectum, and bladder doses in patients with cervical cancer receiving pelvic and para-aortic irradiation. Int J Radiat Oncol Biol Phys 2001, 51:261-266.